Nitric oxide and redox inflammation in cancer

Advances in Molecular Toxicology

Volumn 4, Issue C, 2010, Pages 157-182

  Cheng, Robert ^a   Glynn, Sharon ^a   Flores Santana, Wilmarie ^a   Switzer, Christopher ^a   Ridnour, Lisa ^a   Wink, David A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; MATRIX METALLOPROTEINASE; NITRIC OXIDE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE;

ADAPTIVE IMMUNITY; ANGIOGENESIS; ARTICLE; B LYMPHOCYTE; CANCER CELL; CARCINOGENESIS; CELL MIGRATION; CELL PROLIFERATION; HUMAN; HYPOXIA; IMMUNE RESPONSE; INFLAMMATION; INNATE IMMUNITY; MACROPHAGE; NEOPLASM; NITROSATION; OXIDATION; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; T LYMPHOCYTE; WOUND HEALING;

EID: 77954241355     PISSN: 18720854     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1872-0854(10)04005-1     Document Type: Article

References (126)

1. R.F. Furchgott, J.V. Zawadzki, The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine, Nature 288 (1980) 373-376. (Pubitemid 11169009)
2. D.A. Wink, L.A. Ridnour, S.P. Hussain, C.C. Harris, The reemergence of nitric oxide and cancer, Nitric Oxide 19 (2008) 65-67.
3. J.E. Goodman, L.J. Hofseth, S.P. Hussain, C.C. Harris, Nitric Oxide and p53 in cancer-prone chronic inflammation and oxyradical overload disease, Environ. Mol. Mutagen. 44 (2004) 3-9.
4. D.A. Wink, Y. Vodovotz, J. Laval, F. Laval, M.W. Dewhirst, J.B. Mitchell, The multifaceted roles of nitric oxide in cancer, Carcinogenesis 19 (1998) 711-721. (Pubitemid 28376759)
5. L.A. Ridnour, D.D. Thomas, S. Donzelli, M.G. Espey, D.D. Roberts, D.A. Wink, J.S. Isenberg, The biphasic nature of nitric oxide responses in tumor biology, Antioxid. Redox, Signal 8 (2006) 1329-1337.
6. D.J. Stuehr, Structure-function aspects in the nitric oxide synthases, Annu. Rev. Pharmacol. Toxicol. 37 (1997) 339-359. (Pubitemid 27238880)
7. S.P. Hussain, C.C. Hams, Inflammation and cancer: an ancient link with, novel potentials, Int. J. Cancer 121 (2007) 2373-2380.
8. F.H. Guo, H.R. De Raeve, T.W. Rice, D.J. Stuehr, R.B. Thunnissen, S.C. Erzurum, Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo, Proc. Nad. Acad. Sci. U. S. A. 92 (1995) 7809-7813.
9. S. Ito, O.A. Carretero, K. Abe, Role of nitric oxide in the control of glomerular microcirculation, Clin, Exp. Pharmacol. Physiol, 24 (1997) 578-581.
10. S. Ekmekcioglu, C.H. Tang, E.A. Grimm, NO news is not necessarily good news in cancer, Curr. Cancer Drug Targets 5 (2005) 103-115. (Pubitemid 40488597)
11. D.A. Wink, J.B. Mitchell, Nitric oxide and cancer: An introduction, Free Radic. Biol. Med. 34 (2003) 951-954.
12. D.A. Wink, I. Hanbauer, M.B. Grisham, F. Laval, R.W. Nims, J. Laval, J. Cook, R. Pacelli, J. Liebmann, M. Krishna, P.C. Ford, J.B. Mitchell, The chemical, biology of NO. Insights into regulation, protective and toxic mechanisms of nitric oxide, Curr. Top. Cell. Regud. 34 (1996) 159-187.
13. D.A. Wink, J.B. Mitchell, Chemical biology of nitric oxide: Insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide, Free Radic. Biol. Med. 25 (1998) 434-456.
14. S.D. Cline, J.N. Riggins, S. Tornaletti, L.J. Marnett, P.C. Hanawalt, Malondialdehyde adducts in. DNA arrest transcription by T7 RNA polymerase and mammalian RNA polymerase II, Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 7275-7280. (Pubitemid 38638023)
15. J.D. West, C. Ji, S. T. Duncan, V. Amarnath, C. Schneider, C.J. Rizzo, A.R. Brash, L.J. Marnett, Induction of apoptosis in colorectal carcinoma cells treated with 4hydroxy-2-nonenal and structurally related aldehydic products of lipid peroxidation, Chem. Res. Toxicol, 17 (2004) 453-462.
16. L.A. Ridnour, D.D. Thomas, D. Mancardi, M.G. Espey, K.M. Miranda, N. Paolocci, M. Feelisch, J. Fukuto, D.A. Wink, The chemistry of nitrosative stress induced by nitric oxide and reactive nitrogen oxide species. Putting perspective on stressful biological, situations, Biol. Chem, 385 (2004) 1-10.
17. D.A. Wink, J.A, Cook, S. Kim, Y. Vodovotz, R. Pacelli, M.C. Kirshna, A. Russo, J.B. Mitchell, D. Jourd'heuil, A.M. Miles, M.B. Grisham, Superoxide modulates the oxidation and nitrosation of thiols by nitric oxide derived reactive intermediates, J. Biol. Chem. 272 (1997) 11147-11151.
18. D. jourd'heuil, K.M. Miranda, S.M. Kim, M.G. Espey, Y. Vodovotz, S. Laroux, CT. Mai, A.M. Miles, M.B. Grisham, D.A. Wink, The oxidative and nitrosative chemistry of the nitric oxide/superoxide reaction in the presence of bicarbonate, Arch. Biochem. Biophys. 365 (1999) 92-100.
19. M.G. Espey, S. Xavier, D.D. Thomas, K.M. Miranda, D.A. Wink, Direct real-time evaluation of nitration with green fluorescent protein in solution and within human cells reveals the impact of nitrogen dioxide vs. peroxynitrite mechanisms, Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 3481-3486.
20. M.G. Espey, D.D. Thomas, K.M. Miranda, D.A. Wink, Focusing of nitric oxide mediated nitrosation and oxidative nitrosylation as a consequence of reaction with superoxide, Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 11127-11132.
21. K. Turpaev, C. Bouton, J.C. Drapier, Nitric oxide-derived nitrosating species and gene expression, in human monocytic cells, Biochemistry 43 (2004) 10844-10850.
22. Y. Vodovotz, L. Chesler, H. Chong, S.J. Kim, J.T. Simpson, W. DeGraff, G.W. Cox, A.B. Roberts, D.A. Wink, M.H. Barcellos-Hoff, Regulation of transforming growth, factor betal by nitric oxide, Cancer Res. 59 (1999) 2142-2149.
23. B.N. Ames, L.S. Gold, W.C. Willett, The causes and prevention of cancer, Proc. Natl. Acad, Sci. U. S. A. 92 (1995) 5258-5265.
24. M.E. Turini, R.N. DuBois, Cyclooxygenase-2: A therapeutic target, Annu. Rev. Med. 53 (2002) 35-57.
25. S.P. Hussain, P. Amstad, K. Raja, S. Anibs, M. Nagashima, W.P. Bennett, P.G. Shields, A.J. Ham, J.A. Swenberg, A.J. Marrogi, C.C. Harris, Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: A cancer-prone chronic inflammatory disease, Cancer Res. 60 (2000) 3333-3337.
26. C.A. Colton, Heterogeneity of microglial activation in the innate immune response in the brain, J. Neuroimmune Pharmacol. 4 (2009) 399-418.
27. E.Y. Lin, J.W. Pollard, Macrophages: Modulators of breast cancer progression, Novartis Found. Symp. 256 (2004) 158-168; discussion. 168-172, 259-269.
28. S.O. Hofer, G. Molema, R.A. Hermens, H.J. Wanebo, J.S. Reichner, H.J. Hoekstra, The effect of surgical wounding on tumour development, Eur. J. Surg. Oncol, 25 (1999) 231-243.
29. J. Riss, C. Khanna, S. Koo, G.V. Chandramouli, H.H. Yang, Y. Hu, D.E. Kleiner, A. Rosenwald, C.F. Schaefer, S.A. Ben-Sasson, L. Yang, J. Powell, D.W. Kane, R.A. Star, O. Aprelikova, K. Bauer, J.R. Vasselli, J.K. Maranchie, K.W. Kohn, K.H. Buetow, W.M. Linchan, J.N. Weinstein, M.P. Lee, R.D. Klausner, J.C. Barrett, Caneen as wounds that do not heal.: Differences and similarities between, renal regeneration/repair and renal cell carcinoma, Cancer Res. 66 (2006) 7216-7224.
30. L.C. Green, K. Ruiz de Luzuriaga, D.A. Wagner, W. Rand, N. Istfan, V.R. Young, S.R. Tannenbaum, Nitrate biosynthesis in man, Proc. Natl, Acad. Sci. U. S. A. 78 (1981) 7764-7768.
31. J.S. Wishnok, S.R. Tannenbaum, W.G. Stillwell, J.A. Glogowski, C.D. Leaf, Urinary markers for exposures to alkylating or nitrosating agents, Environ, Health Perspect. 99 (1993) 155-159.
32. R.H. Liu, J.R. Jacob, B.D. Tennant, J.H. Hotchkiss, Nitrite and nitrosamine synthesis by hepatocytes isloated from normal, woodchucks (Marmota monax) and woodchucks chronically infected with woochuck hepatitis virus, Cancer Res. 52 (1992) 4139-4143.
33. F. Laval, D.A. Wink, J. Laval, "A discussion of mechanisms of NO genotoxicty. Implication of inhibtion of DNA repair proteins, Rev. Physiol. Biochem. Pharmacol. 131 (1996) 175-191.
34. D.C. Jenkins, L.G. Charles, L.L. Thomsen, D.W. Moss, L.S. Holmes, S.A. Baylis, P. Rhodes, K. Westmore, P.C. Emson, S. Moneada, Roles of nitric oxide in. tumor growth, Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 4392-4396.
35. D.C. Jenkins, L.G. Charles, S.A. Baylis, R. Lelchuk, M.W. Radomski, S. Moncada, Human colon cancer cell lines show a diverse pattern of nitric oxide synthase gene expression and nitric oxide generation, Br. J. Cancer 70 (1994) 847-849.
36. L.L. Thomsen, F.G. Lawton, R.G. Knowles, J.E. Beesley, V. Riveros-Moreno, and S. Moncada, Nitric oxide synthase activity in human gynecological cancer, Cancer Res. 54 (1994) 1352-1354. (Pubitemid 24108080)
37. L.L. Thomsen, D.W. Miles, L. Happerfield, L.G. Bobrow, R.G. Knowles, S. Moncada, Nitric oxide synthase activity in human breast cancer, Br. J. Cancer 72 (1995) 41-44.
38. K. Xie, Z. Dong, I.J. Fidler, Activation of nitric oxide synthase gene for inhibition of cancer metastasis, J. Leukoc. Biol, 59 (1996) 797-803. (Pubitemid 26238474)
39. K. Xie, S. Huang, Z. Dong, S.H. Juang, M. Gutman, e.Q.W. Xi, C. Nathan, I.J. Fidler, Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1.735 murine melanoma cells. J. Exp. Med. 181 (1995) 1333-1343.
40. M.A. Anttila, K. Voutilainen, S. Merivalo, S. Saarikoski, V.M. Kosma, Prognostic significance of iNOS in epithelial ovarian cancer, Gynecol. Oncol. 105 (2007) 97-103.
41. A. Puhakka, V. Kinnula, U. Napankangas, M. Saily, P. Koistinen, P. Paakko, Y. Soini, High expression, of nitric oxide synthases is a favorable prognostic sign in nonsmall cell lung carcinoma, APMIS 111 (2003) 1137-1146.
42. K.M. Lee, J.Y. Choi, J.E. Lee, D.Y. Noh, S.H. Ahn, W. Han, K.Y. Yoo, R.B. Hayes, D. Rang, Genetic polymorphisms of NOS3 are associated with the risk of invasive breast cancer with lymph node involvement, Breast Cancer Res. Treat. 106 (2007) 433-438.
43. H.H. Chen, W.C. Su, C.Y. Chou, H.R. Guo, S.Y. Ho, J. Que, W.Y. Lee, Increased expression of nitric oxide synthase and cyclooxygenase-2 is associated with poor survival in cervical cancer treated, with radiotherapy, Int. J. Radiat. Oncol. Biol. Phys. 63 (2005) 1093-1100.
44. N. Tanriover, M.O. Ulu, C. Isler, H. Durak, B. Oz, M. Uzan, Z. Akar, Neuronal nitric oxide synthase expression in glial tumors: Correlation, with malignancy and tumor proliferation, Neurol, Res. 30 (2008) 940-944.
45. L. Wang, G.G. Shi, J.C. Yao, W. Gong, D. Wei, T.T. Wu, J.A. Ajani, S. Huang, K. Xie, Expression of endothelial nitric oxide synthase correlates with the angiogenic phenotype of and predicts poor prognosis in human gastric cancer, Gastric Cancer 8 (2005) 18-28. (Pubitemid 40394920)
46. A.S. Bulut, E. Erden, S.D. Sak, H. Doruk, N. Kursun, D. Dincol, Significance of inducible nitric oxide synthase expression in benign and malignant breast epithelium: An immunohistochemical study of 151 cases, Virchows Arch 447 (2005) 24-30.
47. L.G. Li, H.M. Xu, Inducible nitric oxide synthase, nitrotyrosine and apoptosis in gastric adenocarcinomas and their correlation with a poor survival, World J. Gastroenterol. 11 (2005) 2539-2544.
48. J. Shen, R.T. Wang, L.W. Wang, Y.C. Xu, X.R. Wang, A novel genetic polymorphism of inducible nitric oxide synthase is associated with an increased risk of gastric cancer, World J. Gastroenterol. 10 (2004) 3278-3283.
49. C. N. Chen, F.J. Hsieh, Y.M. Cheng, K.J. Chang, P.H. Lee, Expression, of inducible nitric oxide synthase and cyclooxygenase-2 in angiogenesis and clinical outcome of human gastric cancer, J. Surg. Oncol. 94 (2006) 226-233. (Pubitemid 44289987)
50. M. Matsumoto, M. Furihata, A, Kurabayashi, K. Araki, S. Sasaguri, Y. Ohtsuki, Association between inducible nitric oxide synthase expression and p53 status in human esophageal squamous cell carcinoma, Oncology 64 (2003) 90-96. (Pubitemid 35477959)
51. S.H. Aaltoma, P.K. Lipponen, V.M. Kosma, Inducible nitric oxide synthase (iNOS) expression, and its prognostic value in prostate cancer, Anticancer Res. 21 (2001) 3101-3106. (Pubitemid 33051183)
52. S. Ekmekcioglu, J. Ellerhorst, C.M. Smid, V.G. Prieto, M. Munsell, A.C. Buzaid, E.A. Grimm, Inducible nitric oxide synthase and nitrotyrosine in human metastatic melanoma tumors correlate with poor survival, Clin, Cancer Res. 6 (2000) 4768-4775.
53. S. Ekmekcioglu, J.A. Ellerhorst, V.G. Prieto, M.M. Johnson, L.D. Broemeling, E.A. Grimm, Tumor iNOS predicts poor survival for stage III melanoma patients, Int. J. Cancer 119 (2006) 861-866.
54. H. Shigyo, S. Nonaka, A, Katada, N. Bandoh, T. Ogino, A. Katayania, M. Takahara, T. Hayashi, Y. Harabuchi, Inducible nitric oxide synthase expression in various laryngeal lesions in relation to carcinogenesis, angiogenesis, and patients' prognosis, Acta Otolaryngol. 127 (2007) 970-979.
55. M.H. Sun, X.C. Han, M.K. Jia, W.D. Jiang, M. Wang, H. Zhang, G. Han, Y. Jiang, Expressions of inducible nitric oxide synthase and matrix metalloproteinase-9 and their effects on angiogenesis and progression, of hepatocellular carcinoma, World J. Gastroenterol. 11 (2005) 5931-5937.
56. M.C. Levesque, Y. Chen, B.E. Beasley, C.W. O'Loughlin, J.P. Gockerman, J.O. Moore, J.B. Weinberg, Chronic lymphocytic leukemia cell CD38 expression and inducible nitric oxide synthase expression are associated with serum IL-4 levels, Leuk. Res. 30 (2006) 24-28.
57. J.D. Brenton, L.A. Carey, A.A. Ahmed, C. Caldas, Molecular classification and molecular forecasting of breast cancer: Ready for clinical, application? J. Clin. Oncol. 23 (2005) 7350-7360.
58. S.A. Paul, J.W. Simons, N.J. Mabjeesh, HIF at the crossroads between ischemia and carcinogenesis. J. Cell Physiol, 200 (2004) 20-30.
59. D.M. Brizel, G.S. Sibley, L.R. Prosnitz, R.L. Scher, M. Dewhirst, Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck, Int. J. Radiat. Oncol, Biol. Phys. 38 (1997) 285-289.
60. K.S. Siveen, G. Kuttan, Role of macrophages in tumour progression, Immunol. Lett. 123 (2009) 97-102.
61. J.I. Arias, M.A. Aller, F. Sanchez-Patan, J. Arias, Inflammation and cancer: Is trophism the link? Surg. Oncol, 15 (2006) 235-242.
62. C.A. Colton, D.M. Wilcock, Assessing activation, states in microglia, CNS Neurol. Disord. Drug Targets (2009). Oct 7. [Epub ahead of print].
63. F.O. Martinez, A. Sica, A. Mantovani, M. Locad, Macrophage activation, and polarization, Front. Biosci. 13 (2008) 453-461.
64. K. Hall, S. Ran, Regulation of tumor angiogenesis by the local environment, Front. Biosci. 15 (2010) 195-212.
65. R. Kalluri, EMT: When epithelial cells decide to become mesenchymal-like cells. J. Clin. Invest. 119 (2009) 1417-1419.
66. C.W. Leffler, H. Parfenova, J.H. Jaggar, R. Wang, Carbon, monoxide and hydrogen sulfide: Gaseous messengers in cerebrovascular circulation, J. Appl. Physiol. 100 (2006) 1065-1076.
67. A. Schwentker, Y. Vodovotz, R. Weiler, T.R. Billiar, Nitric oxide and wound repair: role of cytokines? Nitric Oxide 7 (2002) 1-10.
68. A.M. Malkinson, Role of inflammation in mouse lung tumorigenesis: A review, Exp. Lung. Res. 31 (2005) 57-82. (Pubitemid 40053570)
69. P.V. Vignais, The superoxide-generating NADPH oxidase: Structural aspects and activation, mechanism, Cell Mol. Life Sci. 59 (2002) 1428-1459.
70. A.M. Miles, M. Gibson, M. Krishna, J.C. Cook, R. Pacelli, D.A. Wink, M.B. Grisham, Effects of superoxide on nitric oxide-dependent N-nitrosation reactions, Free Radic. Res. 233 (1995) 379-390.
71. D. Morse, A.M. Choi, Heme oxygenase-1: The "emerging molecule" has arrived, Am, J. Respir. Cell Mol. Biol. 27 (2002) 8-16.
72. M. Bhatia, Hydrogen sulfide as a vasodilator, IUBMB Life 57 (2005) 603-606.
73. D. Mancardi, C. Pelina, A. Merlino, P. Del. Soldato, D.A. Wink, P. Pagliaro, Physiological and pharmacological features of the novel gasotransmitter: Hydrogen sulfide, Biochim, Biophys. Acta (2009). Acta 1787(7) (2009) 864-872. [Epub 2009 Mar 13].
74. M.A. Marietta, Mammalian synthesis of nitrite, nitrate, nitric oxide and N-nitrosating agents, Chem, Res. Toxicol, 1 (1988) 249-257.
75. R.H. Liu, J.H. Hotchkiss, Potential genotoxicity of chronically elevated nitric oxide: A review, Mutat. Res. 339 (1995) 73-89.
76. J.R. Lancaster, J.B. Hibbs, EPR demonstration of iron-nitrosyl complex formation by cytotoxic activated macrophages, Proc. Natl, Acad. Sci, U. S. A. 87 (1990) 1223-1227.
77. M.G. Espey, K.M. Miranda, R.M. Pluta, D.A. Wink, Nitrosative capacity of macrophages is dependent on nitric-oxide synthase induction signals, J. Biol. Chem. 275 (2000) 11341-11347.
78. L. Connelly, A.T. Jacobs, M. Palacios-Callender, S. Moneada, A.J. Hobbs, Macrophage endothelial nitric-oxide synthase autoregulates cellular activation and proinflammatory protein expression, J. Biol. Chem. 278 (2003) 26480-26487.
79. R. Ogawa, R. Pacelli, M.G. Espey, K.M. Miranda, N. Friedman, S.M. Kim, G. Cox, J.B. Mitchell, D.A. Wink, A. Russo, Comparison of control of Listeria by nitric oxide redox chemistry from murine macrophages and NO donors: Insights into listeriocidal activity of oxidative and nitrosative stress, Free Radic. Biol, Med. 30 (2001) 268-276.
80. D.D. Thomas, L.A. Ridnour, J.S. Isenberg, W. Flores-Santana, C.H. Switzer, S. Donzelli, P. Hussain, C. Vecoli, N. Paolocci, S. Ambs, C.A. Colton, C.C. Harris, D.D. Roberts, D.A. Wink, The chemical biology of nitric oxide: implications in cellular signaling, Free Radic. Biol. Med. 45 (2008) 18-31.
81. L.A. Ridnour, D.D. Thomas, C. Switzer, W. Flores-Santana, J.S. Isenberg, S. Ambs, D.D. Roberts, D.A. Wink, Molecular mechanisms for discrete nitric oxide levels in cancer, Nitric Oxide 19 (2008) 73-76.
82. L.J. Hofseth, S. Saito, S.P. Hussain, M.G. Espey, K.M. Miranda, Y. Araki, C. Jhappan, Y. Higashimoto, P. He, S.P. Linke, M.M. Quezado, I. Zurer, V. Rotter, D.A, Wink, E. Appella, C.C. Harris, Nitric oxide-induced cellular stress and p53 activation in chronic inflammation, Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 143-148.
83. S. Pervin, R. Singh, W.A. Freije, G. Chaudhuri, MKP-1-induced dephosphorylation. of extracellular signal-regulated kinase is essential for triggering nitric oxide-induced apoptosis in human breast cancer cell lines: Implications in breast cancer, Cancer Res. 63 (2003) 8853-8860.
84. L.A. Ridnour, J.S. Isenberg, M.G. Espey, D.D. Thomas, D.D. Roberts, D.A. Wink, Nitric oxide regulates angiogenesis through a functional switch, involving thrombospondin-1, Proc. Natl. Acad, Sci. U. S. A. 102 (2005) 13147-13152.
85. D.D. Thomas, M.G. Espey, L.A. Ridnour, L.J. Hofseth, D. Mancardi, C.C. Harris, D.A. Wink, Hypoxic inducible factor 1alpha, extracellular signal-regulated kinase, and p53 are regulated by distinct threshold concentrations of nitric oxide, Proc. Natl. Acad. Sci, U. S. A. 101 (2004) 8894-8899.
86. C. Wang, L.J. Trudel, G.N. Wogan, W.M. Deen, Thresholds of nitric oxidemediated toxicity in human lyniphoblastoid cells, Chem, Res. Toxicol, 16 (2003) 1004-1013.
87. R.L. Prueitt, B.J. Boersma, T.M. Howe, J.E. Goodman, D.D. Thomas, L. Ying, C.M. Pfiester, H.G. Yfantis, J.R. Cottrell, D.H. Lee, A.T. Remaley, L.J. Hofseth, D.A. Wink, S. Ambs, Inflammation and IGF-I activate the Akt pathway in breast cancer, Int. J. Cancer 120 (2007) 796-805.
88. X. Zhang, Real, time and in vivo monitoring of nitric oxide by electrochemical sensors-from dream to reality, Front. Biosci. 9 (2004) 3434-3446.
89. M.M. Tarpey, D.A. Wink, M.B. Grisham, Methods for detection of reactive metabolites of oxygen and nitrogen: In vitro and in vivo considerations, Am. J. Physiol. Regul. Integr. Comp. Physiol. 286 (2004) R431-R444.
90. M. Laurent, M. Lepoivre, J.P. Tenu, Kinetic modelling of the nitric oxide gradient generated in vitro by adherent cells expressing inducible nitric oxide synthase, Biochem. J. 314 (1996) 109-113.
91. M.S. Colman, C.A. Afshari, J.C. Barrett, Regulation of p53 stability and activity in response to genotoxic stress, Mutat. Res. 462 (2000) 179-188.
92. K. Forrester, S. Ambs, S.E. Lupoid, R.B. Kapust, E.A. Spillare, W.C. Weinberg, E. Felley-Bosco, X.W. Wang, D.A. Geller, E. Tzeng, T. Billiar, C.C. Harris, Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53, Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 2442-2447. (Pubitemid 26104369)
93. S.P. Hussain, P. He, J. Subleski, L.J. Hofseth, C.E. Trivers, L. Mechanic, A.B. Hofseth, M. Bernard, J. Schwank, G. Nguyen, E. Mathe, D. Djurickovic, D. Haines, J. Weiss, T. Back, E. Grays, V.E. Laubach, R.H. Wiltrout, C.C. Harris, Nitric oxide is a key component in inflammation- accelerated tumorigenesis, Cancer Res. 68 (2008) 7130-7136.
94. G. Taraboletti, D. Roberts, L.A. Liotta, R. Giavazzi, Platelet thronibospondin modulates endothelial, cell adhesion, motility, and growth: A potential angiogenesis regulatory factor, J. Cell, Biol. 111 (1990) 765-772. (Pubitemid 20239887)
95. N. Guo, H.C. Krutzsch, J.K. Innian, D.D. Roberts, Thrombospondin 1 and type I repeat peptides of thrombospondin 1 specifically induce apoptosis of endothelial cells, Cancer Res. 57 (1997) 1735-1742.
96. Z. Li, M.J. Calzada, J.M. Sipes, J.A. Cashel, H.C. Krutzsch, D.S. Annis, D.F. Mosher, D.D. Roberts, Interactions of thrombospondins with alpha4beta1 integrin and CD47 differentially modulate T cell behavior, J. Cell. Biol. 157 (2002) 509-519.
97. G. Martin-Manso, S. Galli, L.A. Ridnour, M. Tsokos, D.A. Wink, D.D. Roberts, Thrombospondin 1 promotes tumor macrophage recruitment and enhances tumor cell cytotoxicity of differentiated U937 cells, Cancer Res. 68 (2008) 7090-7099.
98. J.S. Isenberg, F. Hyodo, K. Matsumoto, M.J. Romeo, M. Abu-Asab, M. Tsokos, P. Kuppusamy, D.A. Wink, M.C. Krishna, D.D. Roberts, Thrombospondin-1 limits ischemic tissue survival by inhibiting nitric oxide-mediated vascular smooth muscle relaxation, Blood 109 (2007) 1945-1952.
99. J.S. Isenberg, J.B. Maxhimer, F. Hyodo, M.L. Pendrak, L.A. Ridnour, W.G. DeGraff, M. Tsokos, D.A. Wink, D.D. Roberts, Thrombospondin-1 and CD47 limit cell and tissue survival of radiation injury, Am. J. Pathol. 173 (2008) 1100-1112.
100. J.S. Isenberg, F. Hyodo, L.K. Pappan, M. Abu-Asab, M. Tsokos, M.C. Krishna, W.A. Frazier, D.D. Roberts, Blocking thrombospondin-1/CD47 signaling alleviates deleterious effects of aging on tissue responses to ischemia, Arterioscler. Thromb. Vase. Biol. 27 (2007) 2582-2588.
101. J.S. Isenberg, L.K. Pappan, MJ. Romeo, M. Abu-Asab, M. Tsokos, D.A. Wink, W.A. Frazier, D.D. Roberts, Blockade of thrombospondin-1-CD47 interactions prevents necrosis of full thickness skin grafts, Ann. Surg. 247 (2008) 180-190.
102. M.D. Sternlicht, Z. Werb, How matrix metalloproteinases regulate cell behavior, Annu. Rev. Cell. Dev. Biol. 17 (2001) 463-516. (Pubitemid 33096184)
103. C. Chang, Z. Werb, The many faces of metalloproteases: Cell growth, invasion, angiogenesis and metastasis, Trends Cell. Biol. 11 (2001) S37-S43. (Pubitemid 33001442)
104. L.A. Ridnour, A.N. Windhausen, J.S. Isenberg, N. Yeung, D.D. Thomas, M.P. Vitek, D.D. Roberts, D.A. Wink, Nitric oxide regulates matrix metalloproteinase-9 activity by guanylyl-cyclase-dependent and -independent pathways, Proc. Natl, Acad, Sci. U. S. A. 104(43) (2007) 16898-16903. [Epub 2007 Oct 17].
105. L.M. Coussens, Z. Werb, Inflammation and cancer, Nature 420 (2002) 860-867.
106. W.C. Parks, Matrix metalloproteinases in repair, Wound Repair Regen, 7 (1999) 423-432.
107. T. Okamoto, T. Akuta, F. Tamura, D.V.A. van, T. Akaike, Molecular mechanism for activation and regulation of matrix metalloproteinases during bacterial infections and respiratory inflammation, Biol. Chem. 385 (2004) 997-1006.
108. K.K. Nelson, J.A. Melendez, Mitochondrial redox control of matrix metalloproteinases, Free Radic. Biol, Med. 37 (2004) 768-784.
109. D.A. Siwik, W.S. Colucci, Regulation of matrix metalloproteinases by cytokines and reactive oxygen/nitrogen species in the myocardium, Heart Fail. Rev. 9 (2004) 43-51.
110. G.J. Peppin, S.J. Weiss, Activation of the endogenous metalloproteinase, gelatinase, by triggered human neutrophils, Proc. Natl. Acad. Sci. U. S. A. 83 (1986) 4322-4326.
111. X. Fu, S.Y. Kassim, W.C. Parks, J.W. Heinecke, Hypochlorous acid oxygenates the cysteine switch, domain of pro-matrilysin (MMP-7). A mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture by myeloperoxidase, J. Biol. Chem, 276 (2001) 41279-41287.
112. L.A. Ridnour, A.N. Windhausen, J.S. Isenberg, N. Yeung, D.D. Thomas, M.P. Vitek, D.D. Roberts, D.A. Wink, Nitric oxide regulates matrix metalloproteinase-9 activity by guanylyl-cyclase-dependent and -independent pathways, Proc. Nad. Acad. Sci. U. S. A. 104 (2007) 16898-16903.
113. X. Fu, S.Y. Kassim, W.C. Parks, J.W. Heinecke, Hypochlorous acid generated by myeloperoxidase modifies adjacent tryptophan and glycine residues in the catalytic domain of matrix metalloproteinase-7 (matrilysin): An oxidative mechanism for restraining proteolytic activity during inflammation, J. Biol. Chem. 278 (2003) 28403-28409.
114. X. Fu, J.L. Kao, C. Bergt, S.Y. Kassim, N.P. Huq, A. d'Avignon, W.C. Parks, R.P. Mecham, J.W. Heinecke, Oxidative cross-linking of tryptophan, to glycine restrains matrix metalloproteinase activity: Specific structural motifs control protein oxidation, J. Biol, Chem. 279 (2004) 6209-6212.
115. S.Y. Kassim, X. Fu, W.C. Liles, S.D. Shapiro, W.C. Parks, J.W. Heinecke, NADPH oxidase restrains the matrix metalloproteinase activity of macrophages, J. Biol. Chem. 280 (2005) 30201-30205.
116. Y. Wang, H. Rosen, D.K. Madtes, B. Shao, T.R. Martin, J.W. Heinecke, X. Fu, Myeloperoxidase Inactivates TIMP-I by Oxidizing Its N-terminal Cysteine Residue: An oxidative mechanism for regulating proteolysis during inflammation, J. Biol. Chem, 282 (2007) 31826-31834.
117. P.F. Bove, U.V. Wesley, A.K, Greul, M. Hristova, W.R. Dostmann, d.V.A. van, Nitric oxide promotes airway epithelial wound repair through enhanced activation, of MMP-9, Am. J. Respir. Cell. Mol. Biol. 36 (2007) 138-146.
118. P. Howard-Flanders, Effect of nitric oxide on the radiosensitivity of bacteria. Nature 180(1957) 1191-1192.
119. J.B. Mitchell, D.A. Wink, W. DeGraff, J. Gamson, L.K. Keefer, M.C. Krishna, Hypoxic mammalian cell radiosensitization by nitric oxide, Cancer Res. 53 (1993) 5845-5848. (Pubitemid 24006145)
120. P.J. Wood, L.J. Stratford, G.E. Adams, C. Szabo, C. Thiemerniann, J.R. Vane, Modification of energy metabolism and radiation response of a murine tumour by changes in nitric oxide availability, Biochem. Biophys. Res. Commun. 192 (1993) 505-510.
121. F. Laval, D.A. Wink, Inhibition by nitric oxide of the repair protein. 06-methylguanin-DNA-methyltransferase, Carcinogenesis 15 (1994) 443-447. (Pubitemid 24121689)
122. J.A. Cook, M.C. Krishna, R. Pacelli, W. DeGraff, J. Liebmann, A. Russo, J.B. Mitchell, D.A. Wink, Nitric oxide enhancement of melphalan-induced cytotoxicity, Br. J. Cancer 76 (1997) 325-334. (Pubitemid 27308082)
123. D.A. Wink, J.A. Cook, D. Christodoulou, M.C. Krishna, R. Pacelli, S. Kim, W. DeGraff, J. Gamson, Y. Vodovotz, A. Russo, J.B. Mitchell, Nitric oxide and some nitric oxide donor compounds enhance the cytotoxicity of cisplatin, Nitric Oxide 1 (1997) 88-94.
124. T. Cook, Z. Wang, S. Alber, K. Liu, S.C. Watkins, Y. Vodovotz, T.R. Billiar, D. Blumberg, Nitric oxide and ionizing radiation, synergistically promote apoptosis and growth inhibition of cancer by activating p53, Cancer Res. 64 (2004) 8015-8021.
125. B.F.Jordan, P. Sonveaux, O. Feron, V. Gregoire, N. Beghein, C. Dessy, B. Gallez, Nitric oxide as a radiosensitizer: Evidence for an intrinsic role in addition to its effect on oxygen, delivery and consumption. Int. J. Cancer 109 (2004) 768-773.
126. F. Li, P. Sonveaux, Z.N. Rabbani, S. Liu, B. Yan, Q. Huang, Z. Vujaskovic, M.W. Dewhirst, C.Y. Li, Regulation of HIF-1alpha stability through S-nitrosylation, Mol. Cell, 26 (2007) 63-74. (Pubitemid 46550936)